BSE Live
Nov 06, 16:01Prev. Close
2369.35
Open Price
2393.55
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 06, 16:06Prev. Close
2369.50
Open Price
2375.00
Bid Price (Qty.)
2308.00 (15)
Offer Price (Qty.)
2308.10 (152)
| Balance Sheet of Mankind Pharma (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 40.06 | 40.06 | 40.06 | 20.03 | 20.03 | |
| Total Share Capital | 40.06 | 40.06 | 40.06 | 20.03 | 20.03 | |
| Reserves and Surplus | 3,611.39 | 3,024.76 | 2,956.89 | 2,618.66 | 2,046.56 | |
| Total Reserves and Surplus | 3,611.39 | 3,024.76 | 2,956.89 | 2,618.66 | 2,046.56 | |
| Total Shareholders Funds | 3,651.45 | 3,064.82 | 2,996.95 | 2,638.69 | 2,066.59 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Liabilities [Net] | 0.00 | 18.00 | 29.08 | 39.21 | 0.00 | |
| Other Long Term Liabilities | 17.47 | 10.18 | 7.56 | 4.92 | 0.00 | |
| Long Term Provisions | 46.41 | 32.43 | 25.61 | 21.72 | 14.90 | |
| Total Non-Current Liabilities | 63.89 | 60.60 | 62.25 | 65.85 | 14.90 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 0.00 | 190.00 | 360.00 | 0.00 | 0.00 | |
| Trade Payables | 487.23 | 397.89 | 452.33 | 368.49 | 326.67 | |
| Other Current Liabilities | 159.31 | 81.32 | 113.71 | 85.11 | 67.37 | |
| Short Term Provisions | 169.23 | 77.32 | 40.98 | 12.29 | 1.46 | |
| Total Current Liabilities | 815.77 | 746.53 | 967.03 | 465.89 | 395.49 | |
| Total Capital And Liabilities | 4,531.11 | 3,871.95 | 4,026.22 | 3,170.43 | 2,476.98 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 917.35 | 762.16 | 506.01 | 474.44 | 241.45 | |
| Intangible Assets | 21.90 | 5.36 | 6.43 | 6.99 | 6.11 | |
| Capital Work-In-Progress | 143.93 | 211.11 | 322.41 | 141.12 | 0.00 | |
| Other Assets | 5.51 | 10.39 | 11.40 | 187.85 | 0.00 | |
| Fixed Assets | 1,092.39 | 989.02 | 846.25 | 810.39 | 324.14 | |
| Non-Current Investments | 1,389.51 | 1,383.85 | 854.07 | 291.83 | 315.49 | |
| Deferred Tax Assets [Net] | 21.05 | 60.13 | 0.00 | 0.00 | 1.26 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 552.76 | |
| Other Non-Current Assets | 79.56 | 37.20 | 66.90 | 234.13 | 0.17 | |
| Total Non-Current Assets | 2,582.50 | 2,470.21 | 1,767.22 | 1,336.36 | 1,193.82 | |
| CURRENT ASSETS | ||||||
| Current Investments | 394.16 | 314.17 | 547.66 | 694.41 | 533.16 | |
| Inventories | 533.48 | 481.50 | 468.81 | 522.26 | 410.15 | |
| Trade Receivables | 418.62 | 149.78 | 242.52 | 137.30 | 157.39 | |
| Cash And Cash Equivalents | 197.95 | 72.48 | 81.35 | 91.95 | 71.81 | |
| Short Term Loans And Advances | 211.88 | 251.34 | 358.87 | 320.75 | 95.81 | |
| OtherCurrentAssets | 192.51 | 132.48 | 559.80 | 67.40 | 14.83 | |
| Total Current Assets | 1,948.60 | 1,401.75 | 2,259.00 | 1,834.07 | 1,283.15 | |
| Total Assets | 4,531.11 | 3,871.95 | 4,026.22 | 3,170.43 | 2,476.98 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 0.00 | 0.00 | 110.63 | 0.00 | 0.00 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 15.11 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 31,950.00 | 4,723,000.00 | 32.31 | 0.00 | 9.41 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | 11.43 | |
| Other Earnings | 52,160.00 | 4,677,000.00 | 90.04 | 24.04 | 33.05 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 5.19 | 5.19 | 5.19 | 5.19 | 5.19 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 1,389.51 | 1,383.85 | 854.07 | 291.83 | 315.49 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | 571.05 | |
| Current Investments Unquoted Book Value | 394.16 | 314.17 | 547.66 | 694.41 | -- |
13.10.2025
19.09.2025
11.09.2025
05.08.2025
01.08.2025
Mankind Pharma Consolidated June 2025 Net Sales at Rs 3,570.35 crore, up 23.4% Y-o-Y
01.08.2025
Mankind Pharma Standalone June 2025 Net Sales at Rs 2,541.36 crore, up 5.75% Y-o-Y
24.06.2025
Mankind Pharma Consolidated March 2025 Net Sales at Rs 3,079.37 crore, up 26.15% Y-o-Y
22.05.2025
Mankind Pharma Consolidated March 2025 Net Sales at Rs 3,079.37 crore, up 26.15% Y-o-Y